Pfizer, BioNTech Ask FDA To Authorize Bivalent COVID-19 Vaccine For Children Under Age Five

The AP (12/5, Neergaard) reports, “Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 – not as a booster but part of their initial shots.” The article adds, “Children ages 6 months through 4 years already a...